Dow gains 369 points on trader optimism around a COVID-19 treatment

Dow gains 369 points on trader optimism around a COVID-19 treatment

Business Insider

Published

· *US stocks rose on Friday as traders cheered advances in coronavirus treatment.*
· *Gilead Sciences said on Friday that an analysis of clinical-trial data for its remdesivir drug found a 62% reduction in mortality risk among severe COVID-19 patients.*
· *Still, the US on Thursday reported 63,200 new coronavirus cases,...

Full Article